Target intelligence / Profile preview

Sin3A associated protein 25 (SAP25)

Target
SAP25
Molecular classification
Chromatin remodeling complex protein, Histone modification, Transcriptional corepressor complex component, Other (Sin3/HDAC complex subunit)
01

Overview

Sin3A associated protein 25 (SAP25) is a protein subunit of the Sin3A/HDAC transcriptional corepressor complex, involved predominantly in the negative regulation of gene expression through chromatin remodeling and histone deacetylation[1][2][6]. SAP25 acts as an adaptor protein, interacting with multiple protein complexes such as deubiquitinases (USP11), E3 ubiquitin ligases (SCF(FBXO3)), O-linked N-acetylglucosamine transferase (OGT), and TET methylcytosine dioxygenases, in addition to core Sin3/HDAC complex members[2]. These interactions enable SAP25 and the Sin3/HDAC complex to precisely control gene expression, particularly in the context of the immune response and potentially in neurodevelopmental processes[1][2]. There is currently no direct evidence that SAP25 is a drug target, nor are drugs, biomarkers, or safety concerns associated directly with SAP25 established in the literature[1][2][6].

Other names
Histone deacetylase complex subunit SAP25Sin3 corepressor complex subunit SAP2525 kDa Sin3-associated polypeptideSin3A-associated protein, 25kDaFLJ00248Sin3-associated polypeptide, 25kDaSin3A-binding protein 25
02

Biological functions

Negative regulation of DNA-templated transcription[1][6]Transcriptional repression via chromatin modification (as part of the Sin3A/HDAC complex)[2][1]Adaptor for recruiting enzymatic complexes (including deubiquitinases, E3 ligases, and glycosylases) for chromatin regulation[2]
03

Disease associations

Other (implicated in gene regulation affecting immune response and potentially neurodevelopmental and intellectual disability disorders, but not directly established as a disease driver)[2]

Beyond the preview

Go deeper on Sin3A associated protein 25 (SAP25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sin3A associated protein 25 (SAP25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call